 |
市场调查报告书
商品编码
1529907
生育药物市场：按药物类型、给药途径、性别、分销管道和地区分类Infertility Drugs Market, By Drug Type, By Route of Administration, By Gender, By Distribution Channel, By Geography |
||||||
预计2024年全球生育药物市场规模为39.1亿美元，预计到2031年将达61亿美元，2024年至2031年复合年增长率为6.6%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 39.1亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测期，2024-2031年复合年增长率： | 6.60% | 2031 年金额预测 | 61亿美元 |
不孕症是指即使您经常进行无保护的性行为，也无法自然怀孕。在全球范围内，不孕症是一个普遍存在的社会和健康问题。推动全球生育药物市场成长的是男性和女性不孕症盛行率的不断上升。压力程度增加、生活型态改变、肥胖、性行为感染和遗传异常等危险因子导致男性和女性不孕症盛行率增加。辅助生殖技术的进步和不孕症治疗成功率的提高为数百万苦苦挣扎的夫妇带来了希望。多家製药公司提供多种生育药物，可以治疗排卵障碍、荷尔蒙失衡和其他不孕症相关问题。
市场动态：
全球生育药物市场的成长是由不孕率上升、妇科疾病盛行率增加、对不孕症及其治疗方法的认识不断提高、医疗保健支出增加、不孕症治疗方法技术进步、政府和其他组织的财政支持等因素推动的。然而，不孕症治疗的高成本、不孕症治疗相关的併发症和风险、严格的法律规范以及一些国家的文化和社会障碍等因素可能会阻碍市场成长。全部区域越来越多的不孕症治疗和体外受精诊所可能会提供利润丰厚的成长机会。由于医疗旅游的增加和有利的监管，新兴国家具有巨大的成长潜力。
本研究的主要特点
该报告对全球不孕症治疗市场进行了详细分析，以2023年为基准年估计了预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
根据公司亮点、产品系列、主要亮点、业绩和策略等参数对全球生育药物市场的主要企业进行了分析。
本研究涵盖的主要企业包括默沙东、辉凌製药、丽珠医药集团、艾伯维、默沙东等。
本报告中的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球生育药物市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球生育药物市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章 市场动态、法规与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球生育药物市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球生育药物市场，依药物类型，2019-2031（十亿美元）
- 克罗米芬柠檬酸盐
- 性荷尔蒙
- 促性腺激素分泌
- 溴隐亭
- 卡麦角林
- 丙咪嗪
- 来曲唑
- Metformin
第六章 全球生育药物市场，依给药途径，2019-2031 年（十亿美元）
- 口服
- 胃肠外的
第七章全球生育药物市场，性别，2019-2031（十亿美元）
- 男性
- 女士
第八章全球生育药物市场，按分销管道，2019-2031（十亿美元）
- 医院药房
- 零售药房
- 网路药房
第九章全球生育药物市场，按地区，2019-2031（十亿美元）
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
第10章竞争格局
- 公司简介
- Merck &Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, SA
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech（Finox AG）
第十一章分析师建议
- 命运之轮
- 分析师观点
- Coherent Opportunity Map
第十二章参考文献与调查方法
- 参考
- 调查方法
Global infertility drugs market is estimated to be valued at USD 3.91 Bn in 2024 and is expected to reach USD 6.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 3.91 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.60% | 2031 Value Projection: | US$ 6.10 Bn |
Infertility refers to the inability to conceive a child naturally after a period of regular unprotected sexual intercourse. Globally, infertility is a widely prevalent issue with societal and health implications. Global infertility drugs market growth is driven by increasing incidence of infertility among both men and women. Risk factors like rising stress levels, lifestyle changes, obesity, sexually transmitted diseases, and genetic abnormalities have contributed to growing prevalence of both male and female infertility. Advancements in assisted reproductive technologies and increasing success rates of infertility treatment procedures have provided hope to millions of struggling couples. Several pharmaceutical companies offer a wide range of infertility medications that can treat ovulation disorders, hormonal imbalances, and other fertility-related issues.
Market Dynamics:
Global infertility drugs market growth is driven by factors such as rising infertility rates, increasing prevalence of gynecological disorders, growing awareness about infertility and treatment options, rising healthcare expenditure, technological advancements in fertility treatment procedures, and the financial assistance provided by governments and other organizations. However, factors such as high cost of infertility treatment, complications and risk associated with infertility therapy, stringent regulatory framework, and cultural and social barriers in some nations can hamper the market growth. Growing number of fertility and IVF clinics across developing regions can offer lucrative growth opportunities. Emerging economies offer significant growth potential due to increasing medical tourism and favorable regulations.
Key Features of the Study:
This report provides in-depth analysis of the global infertility drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global infertility drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbVie Inc., and MSD
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global infertility drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infertility drugs market
Detailed Segmentation-
- By Drug Type
- Clomiphene citrate
- Sex hormones
- Gonadotropins
- Bromocriptine
- Cabergoline
- Imipramine
- Letrozole
- Metformin
- By Gender
- Male
- Female
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck & Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Gender
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Infertility Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Infertility Drugs Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Clomiphene citrate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Sex hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gonadotropins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Bromocriptine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cabergoline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Imipramine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Letrozole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Metformin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Infertility Drugs Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Infertility Drugs Market, By Gender, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Infertility Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Infertility Drugs Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
- Merck & Co., Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
全球不孕症药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测
排卵预测套件市场：按类型、应用分类 - 2025-2030 年全球预测
2024-2032 年按药物类别（促性腺激素、芳香酶抑制剂、选择性雌激素受体调节剂、双胍类等）、给药途径、配销通路、最终用户和地区分類的不孕不育药物市场报告
PCOS 诊断市场：按诊断测试类型、最终用户、地区
排卵预测套件市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型、应用、地区和竞争细分
PCOS 诊断市场全球行业规模、份额、趋势、机会、预测，2018-2028 年，按测试类型、最终用户、地区、竞争
不孕治疗药的全球市场(2022年～2028年)
生育药物全球市场规模、份额、行业趋势分析报告：按最终用户、分销渠道（医院药房、专业/零售药房、在线药房）、药物类别、地区、展望和预测，2022-2028 年版
生育药物市场规模份额和趋势分析报告:按药物(促性腺激素,芳香□抑製剂,SERM,多巴胺激动剂),用途(男性,女性),分销渠道,地区,细分市场预测2023～2030